Isradipine and hepatic steatosis Patient Reports February 13, 2012

Isradipine Side Effects Report #5605693-9
Isradipine side effect was reported by a Consumer or non-health professional from SWITZERLAND on Jan 16, 2008. Female patient, 57 years of age, was diagnosed with liver transplant  and was treated with Isradipine. After drug was administered, patient experienced the following side effects: hepatic fibrosis, hepatic steatosis. Isradipine dosage: 2.5 MG; QD; PO. During the same period patient was treated with NEORAL, COPEGUS, PEGINTERFERON ALFA, OMEPRAZOLE, POTASSIUM CHLORIDE, COZAAR, FUROSEMIDE. Patient recovered.

Isradipine Side Effects Report #5786203-2
Isradipine side effect was reported by a Consumer or non-health professional from FRANCE on June 20, 2008. Female patient, 57 years of age, was diagnosed with liver transplant  and was treated with Isradipine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, biliary tract disorder, blood alkaline phosphatase increased, blood bilirubin increased, gamma-glutamyltransferase increased, hepatic fibrosis, hepatic steatosis, liver function test abnormal. Isradipine dosage: 2.5MG PER DAY. During the same period patient was treated with NEORAL, COPEGUS, PEGASYS, OMEPRAZOLE, POTASSIUM CHLORIDE, COZAAR, LASIX. Patient recovered.